Hologic (HOLX) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal optimism; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Hologic (HOLX) PT Lowered to $48 at Piper Jaffray Following 4Q Release
November 9, 2017 8:19 AM ESTPiper Jaffray lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $51.00) while maintaining a Overweight rating following the company's 4Q earnings report. Hologic reported a 10.5% 4Q17 revenue increase to $802.9M, above $793M consensus. Adjusted EPS of $0.50 beat the Street's $0.49 forecast. Hologic issued 2018 revenue... More
